Share on StockTwits

Healthways (NASDAQ:HWAY) was upgraded by stock analysts at Noble Financial from a “hold” rating to a “buy” rating in a report issued on Friday, TheFlyOnTheWall.com reports. The firm currently has a $21.00 target price on the stock. Noble Financial’s price target would indicate a potential upside of 30.60% from the company’s current price.

A number of other firms have also recently commented on HWAY. Analysts at Stifel Nicolaus reiterated a “buy” rating on shares of Healthways in a research note on Friday. They now have a $21.00 price target on the stock, up previously from $17.00. Separately, analysts at Jefferies Group initiated coverage on shares of Healthways in a research note on Wednesday, April 9th. They set a “hold” rating and a $17.00 price target on the stock. Finally, analysts at Dougherty & Co downgraded shares of Healthways from a “buy” rating to a “neutral” rating in a research note on Friday, February 14th. Three research analysts have rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $16.57.

Shares of Healthways (NASDAQ:HWAY) opened at 16.08 on Friday. Healthways has a one year low of $9.59 and a one year high of $22.20. The stock’s 50-day moving average is $16.34 and its 200-day moving average is $14.92. The company’s market cap is $566.1 million.

Healthways (NASDAQ:HWAY) last posted its quarterly earnings results on Thursday, April 24th. The company reported ($0.07) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.12) by $0.05. The company had revenue of $176.80 million for the quarter, compared to the consensus estimate of $177.13 million. During the same quarter in the prior year, the company posted ($0.12) earnings per share. The company’s quarterly revenue was up 7.0% on a year-over-year basis. Analysts expect that Healthways will post $0.11 EPS for the current fiscal year.

Healthways, Inc provides solutions to help people improve physical, emotional and social well-being. The Company provides specific and personalized interventions for each individual in a population, irrespective of health status, age or payor.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.